2024 asa guidance glp-1 receptor agonists perioperative A narrative review of glucagon-like peptide-1 prior to deep sedation or general anesthesia Glucagon-Like Peptide 1 Receptor Agonists

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide).

While these agents are not recommended during pregnancy, their use in the preconception, periconception, and postpartum periods is increasing

What is Retatrutide

A new short-term CMS demonstration changes that for 18 months.

CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs for Americans with Medicare and Medicaid.